最近在耐火性胃肠道血管扩张症治疗方面的进展
Aymeric Becq1, Reena Sidhu2,3, Lia C M J Goltstein4
1Gastroenterology Department, Paris-Est Créteil University, Henri Mondor Hospital, AP HP, Créteil, France.
United European gastroenterology journal
|September 4, 2024
概括
耐火性胃肠道血管扩张 (GIA) 出血可以通过非内镜治疗. 索马托斯塔丁类同类药物和抗血管性药物为GIA提供有效的治疗方法,大动脉置换对海德综合征有益.
科学领域:
- 胃肠病学 胃肠病学
- 血管医学 血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 胃肠道血管扩张 (GIA) 是一种常见的血管形,导致消化道出血.
- 耐火性GIA的特点是经常出现出血,输血或重复内镜检查.
- 对于GIA,非内镜管理策略越来越重要.
研究的目的:
- 审查关于耐火性胃肠道血管扩张的非内镜治疗的最新更新.
- 突出有效的药理和干预治疗GIA相关出血的方法.
- 讨论基于GIA病理生理学的未来治疗方向.
主要方法:
- 关于GIA管理的最新高质量出版物的文献综述.
- 专注于非内镜治疗方式.
- 对药理学药剂和外科手术的分析.
主要成果:
- 大动脉置换是有效的GIA在海德综合征.
- 像Octreotide和Thalidomide这样的抗血管性药物对于耐火性GIA出血是有效的.
- 索马托斯塔丁类似物显示出良好的疗效和耐受性.
结论:
- 非内镜治疗,特别是体静止素类型,对于耐火性GIA非常有价值.
- 手术干预 (大动脉置换) 适用于海德综合征中的GIA.
- 进一步了解GIA病理生理学可能会导致新的向疗法.
相关概念视频
Inflammatory Bowel Disease V: Surgical Management
133
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
133
Gastroesophageal Reflux Disease II: Clinical Features and Management
62
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
62
Esophageal Varices-II: Clinical Features and Management
57
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
57
Peptic Ulcer Disease IV: Management
78
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
78
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


